|
02/09/2013 |
D002/Lyprinol for osteoarthritis |
CPN |
Registered |
|
22/08/2013 |
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) |
CIGB |
Registered |
|
05/05/2020 |
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial |
BIOCEN |
Registered |
|
28/11/2017 |
Bioequivalence of Phenytoin |
CIDEM |
Registered |
|
04/10/2017 |
Bioequivalence of diclofenac sodium retard |
CIDEM |
Registered |
|
04/02/2022 |
VALIDATION OF AUTOMATIC DEVICES IN THE CLINIC: VALIDAC-1 |
ICCCV |
Registered |
|
27/01/2017 |
Pharmacovigilance-VALERGEN-Asthma |
BIOCEN |
Registered |
|
03/03/2023 |
Kardioli® nutritional supplement versus placebo in patients with chronic heart failure. Phase II. |
CATALYSIS |
Registered |
|
03/08/2020 |
Biomodulina T in pediatric septic shock. Exploratory study |
BIOCEN |
Registered |
|
04/12/2015 |
Study of the meningococcal ACW135 polysaccharide vaccine |
FINLAY |
Registered |
|
26/10/2021 |
VISION Study |
CIGB |
Registered |
|
29/11/2017 |
Bioequivalence of Zidovudine |
CIDEM |
Registered |
|
22/12/2017 |
Bioequivalence of Efavirenz |
CIDEM |
Registered |
|
16/10/2017 |
Chitosan Unguent in burned patients |
CIDEM |
Registered |
|
30/05/2018 |
Results of an antimicrobial stewardship program |
CenQfal |
Registered |
|
03/03/2023 |
Nimotuzumab in the treatment of patients with acute respiratory difficulty syndrome (ARDS) |
CIM |
Registered |
|
14/08/2014 |
Study of intensive pediatric pharmacovigilance of nimotuzumab for the treatment of malignant glioma tumors. |
CIMAB |
Registered |
|
28/11/2017 |
Bioequivalence of Diltiazem retard |
CIDEM |
Registered |
|
28/11/2017 |
Bioequivalence of Sildenafil |
CIDEM |
Registered |
|
30/01/2018 |
Bioequivalence of Trienor |
CIDEM |
Registered |
